Xuezhikang Therapy Increases miR-33 Expression in Patients with Low HDL-C Levels
Open Access
- 1 January 2014
- journal article
- research article
- Published by Wiley in Disease Markers
- Vol. 2014, 1-5
Abstract
Background. MicroRNA-33a and -b (miR-33a/b) have been revealed to be posttranscriptional regulators of HDL metabolism. Xuezhikang (XZK) is a marked natural HDL-raising polypill. We aim to evaluate the effects of XZK on the expression of circulating miR-33a/b in patients with low plasma HDL-C levels.Methods. A total of 42 participating patients with low baseline levels of HDL cholesterol were assigned to receive an XZK capsule, 600 mg twice daily for 6 months. The expression of circulating miR-33a/b was detected at baseline and after XZK therapy measured with quantitative reverse-transcription (RT) polymerase chain reaction (PCR).Results. The mean (SD) HDL-C level after XZK treatment was 1.19 (0.13) mmol/L, representing an increase of 11.2% from baseline (). Q-PCR analysis of plasma miRNAs revealed an increase in relative miR-33a/b expression with XZK treatment. The miR-33a expression was raised from 0.81 to 1.73 (); miR-33b expression was increased from 1.2 to 2.75 (). The changes of miR-33a and miR-33b were inversely related to the posttreatment LDL-C levels (,;,, resp.).Conclusion. In patients with low HDL-C levels, XZK therapy raised plasma levels of miR-33a and miR-33b, which may inhibit cellular cholesterol export and limit the HDL-raising effect of XZK.
Keywords
Funding Information
- National Natural Science Foundation of China (81270941, 81100878, 2013CB530804, 11KMM27)
- National Natural Science Foundation of China (81270941, 81100878, 2013CB530804, 11KMM27)
- Key National Basic Research Program of China (81270941, 81100878, 2013CB530804, 11KMM27)
- Chinese PLA General Hospital (81270941, 81100878, 2013CB530804, 11KMM27)
This publication has 16 references indexed in Scilit:
- Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin TherapyNew England Journal of Medicine, 2011
- The Emerging Role of Epigenetics in StrokeArchives of Neurology, 2010
- Serum microRNA characterization identifies miR-885-5p as a potential marker for detecting liver pathologiesClinical Science, 2010
- Plasma MicroRNA Profiling Reveals Loss of Endothelial MiR-126 and Other MicroRNAs in Type 2 DiabetesCirculation Research, 2010
- MiR-33 Contributes to the Regulation of Cholesterol HomeostasisScience, 2010
- Circulating microRNAs are new and sensitive biomarkers of myocardial infarctionEuropean Heart Journal, 2010
- Circulating microRNAs as stable blood-based markers for cancer detectionProceedings of the National Academy of Sciences, 2008
- Effect of Xuezhikang, an Extract From Red Yeast Chinese Rice, on Coronary Events in a Chinese Population With Previous Myocardial InfarctionThe American Journal of Cardiology, 2008
- Effect of Torcetrapib on the Progression of Coronary AtherosclerosisNew England Journal of Medicine, 2007
- High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies.Circulation, 1989